Bayer Healthcare Pharmaceuticals - Strategy and SWOT Report,
is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Bayer Healthcare Pharmaceuticals required for business and competitor intelligence needs
A study of the major internal and external factors affecting Bayer Healthcare Pharmaceuticals in the form of a SWOT analysis
An in-depth view of the business model of Bayer Healthcare Pharmaceuticals including a breakdown and examination of key business segments
Intelligence on Bayer Healthcare Pharmaceuticals’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Bayer Healthcare Pharmaceuticals, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Bayer HealthCare Pharmaceuticals (Bayer Pharma or 'the company'), a business division of Bayer, primarily focuses on the development and commercialization of drugs in cardiovascular and blood diseases, oncology, ophthalmology and women's healthcare. It operates in Europe, the Americas, Asia Pacific, Africa and Middle East. The company is headquartered in Berlin, Germany and employed about 39,000 people as on December 31, 2014.
Reasons to Purchase:
Gain understanding of Bayer Healthcare Pharmaceuticals and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Bayer Healthcare Pharmaceuticals as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Bayer Healthcare Pharmaceuticals’s business structure, strategy and prospects